We are live on ! Find out more
SI

Stephens Inc Portfolio holdings

AUM $7.99B
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+19.81%
1 Year Est. Return
+21.6%
3 Year Est. Return
+65.6%
5 Year Est. Return
+78.01%
10 Year Est. Return
+239.95%
AUM
$4.65B
AUM Growth
+$897M
Cap. Flow
+$221M
Cap. Flow %
4.76%
Top 10 Hldgs %
20.36%
Holding
1,223
New
119
Increased
453
Reduced
486
Closed
77

Sector Composition

Rank Sector Weight
1 Technology 9.41%
2 Financials 8.38%
3 Healthcare 7.02%
4 Consumer Staples 5.56%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
626
State Street SPDR S&P Dividend ETF
SDY
$22.3B
$666K 0.01%
7,298
+321
+5% +$28.2K
GFY
627
DELISTED
Western Asset Variable Rate Strategic Fund, Inc
GFY
$666K 0.01%
42,429
-1,575
-4% -$23.7K
PVH icon
628
PVH
PVH
$4.01B
$664K 0.01%
13,827
+4,049
+41% +$189K
MKC icon
629
McCormick & Company Non-Voting
MKC
$13.9B
$661K 0.01%
7,366
-986
-12% -$81.2K
BSCN
630
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$661K 0.01%
30,394
+1,910
+7% +$41K
DXCM icon
631
DexCom
DXCM
$28.9B
$658K 0.01%
6,488
-1,872
-22% -$167K
FNX icon
632
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.39B
$657K 0.01%
10,508
-583
-5% -$33.4K
BSCO
633
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$656K 0.01%
29,757
+2,750
+10% +$59.5K
PPLI
634
People Inc
PPLI
$3.13B
$655K 0.01%
11,325
+1,617
+17% +$71.8K
NBIX icon
635
Neurocrine Biosciences
NBIX
$18.4B
$648K 0.01%
5,312
PCRX icon
636
Pacira BioSciences
PCRX
$1.05B
$647K 0.01%
12,322
-682
-5% -$28.5K
CRSP icon
637
CRISPR Therapeutics
CRSP
$4.68B
$643K 0.01%
+8,752
New +$512K
TEI
638
Templeton Emerging Markets Income Fund
TEI
$314M
$643K 0.01%
81,857
-309
-0.4% -$2.35K
B
639
Barrick Mining
B
$61.5B
$642K 0.01%
23,820
-1,897
-7% -$47.4K
IYH icon
640
iShares US Healthcare ETF
IYH
$3.46B
$636K 0.01%
14,745
TPIC
641
DELISTED
TPI Composites
TPIC
$635K 0.01%
27,170
-5,750
-17% -$108K
VG
642
DELISTED
Vonage Holdings Corporation
VG
$633K 0.01%
62,915
+1,861
+3% +$16.7K
AMD icon
643
Advanced Micro Devices
AMD
$741B
$631K 0.01%
11,990
+1,478
+14% +$78.4K
BSX icon
644
Boston Scientific
BSX
$68.5B
$629K 0.01%
17,916
+3,777
+27% +$136K
DGRO icon
645
iShares Core Dividend Growth ETF
DGRO
$43.3B
$623K 0.01%
16,560
-21,910
-57% -$797K
PKG icon
646
Packaging Corp of America
PKG
$22.6B
$622K 0.01%
6,229
-330
-5% -$31.4K
NTR icon
647
Nutrien
NTR
$33.3B
$619K 0.01%
19,279
+878
+5% +$30.6K
GM icon
648
General Motors
GM
$81.7B
$615K 0.01%
24,320
+868
+4% +$21.1K
TXRH icon
649
Texas Roadhouse
TXRH
$13.5B
$613K 0.01%
+11,666
New +$569K
ANSS
650
DELISTED
Ansys
ANSS
$610K 0.01%
2,092
-20
-0.9% -$5.33K

Similar funds

Stephens Inc's Q2 2020 Portfolio in Review

As of Q2 2020, Stephens Inc held 1,223 positions worth $4.65B, up 24% from $3.76B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Stephens Inc deployed $221M of net new capital in Q2 2020, opening 119 new positions and adding to 453 existing holdings. Its largest new stake was Cambria Tail Risk ETF: 662,280 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $8.63M trimmed.

  • Stephens Inc's largest Q2 2020 buy was Cambria Tail Risk ETF: 662,280 shares worth $14.7M.
  • Stephens Inc added most to JPMorgan Ultra-Short Income ETF in Q2 2020, an estimated $72.3M increase.
  • Stephens Inc's biggest Q2 2020 reduction was Vanguard Mid-Cap ETF, cutting an estimated $8.63M.
  • Stephens Inc fully exited Golub Capital BDC in Q2 2020, selling an estimated $26M.
  • Stephens Inc's ten largest holdings make up 20% of its $4.65B portfolio in Q2 2020.
  • Stephens Inc opened 119 new positions and closed 77 in Q2 2020.
  • Stephens Inc's portfolio value rose 24% quarter-over-quarter to $4.65B.

Based on Stephens Inc's 13F filing for Q2 2020, filed 24 Aug 2020.